Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for chronic central serous chorioretinopathy
IRCT2015092224140N1Phase 3Completed
- Sponsor
- National Eye Research Network
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of spironolactone in Central Serous Chorioretinopathy (CSCR), sponsored by National Eye Research Network. Started Oct 2015; status: completed.
02
Drugs
spironolactone
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on IRCT2015092224140N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015092224140N1.